INDIVIDUALIZED HOMOEOPATHIC TREATMENT WITH RHUS TOXICODENDRON IN SCIATICA: CHANGES IN PAIN AND DISABILITY IN A PROSPECTIVE SINGLE-ARM INTERVENTIONAL STUDY
DOI:
https://doi.org/10.5281/10.5281/zenodo.24374760Keywords:
Homoeopathy; Sciatica; Rhus toxicodendron; Clinical outcomes; Oswestry Disability Index; McGill Pain Questionnaire; Pain managementAbstract
Background: Sciatica is a common cause of pain and disability in adults, most often due to lumbar disc disease or degenerative spinal change. Conventional treatment with NSAIDs, analgesics, muscle relaxants, corticosteroids and surgery is limited by recurrence and adverse effects, and other approaches merit study. Rhus toxicodendron is one of the remedies most frequently prescribed for sciatica in homoeopathy, but prospective data on its outcomes, measured with validated pain and disability instruments, are limited.
Objective: To assess changes in pain and functional disability over three months in patients with sciatica treated with individualized Homoeopathic medicine Rhus toxicodendron, and to observe the clinical course.
Methods: In this prospective single-arm interventional study, 30 patients aged 30-75 years presenting with sciatica at the OPD, IPD and peripheral centres of Sarada Krishna Homoeopathic Medical College were studied. Detailed case taking was carried out using the standardized chronic case format. Diagnosis was based on symptom presentation, physical and clinical examination and a positive Straight Leg Raising test, with X-rays in all patients and MRI wherever needed. The symptoms were repertorised using Synthesis Repertory 9.1 in RADAR Opus, and only patients in whom Rhus toxicodendron was the indicated remedy after repertorisation were included. Rhus toxicodendron was started in 30C potency, and repetition and change of potency to 200C or 1M, followed the Organon of Medicine and according to the susceptibility of the patient. Follow-up was every 15 days for three months. Pain was assessed before and after treatment with the Short-Form McGill Pain Questionnaire (Pain Rating Index, Present Pain Intensity and Visual Analogue Scale) and disability with the Modified Oswestry Disability Index (ODI). Scores were compared using the Wilcoxon signed-rank test.
Results: Of the 30 cases studied, the majority belonged to the age group of 30-59 years (86.67%), and females constituted 70% of the study population. Scores were lower after treatment in every patient: the mean Pain Rating Index fell from 27.13 ± 4.16 to 12.83 ± 7.91, VAS from 74.33 ± 5.04 mm to 39.67 ± 17.12 mm and ODI from 57.10 ± 6.74 to 20.13 ± 18.22 (p < 0.001). Nineteen cases (63.33%) showed marked improvement, 2 (6.67%) moderate, 6 (20.00%) mild and 3 (10.00%) no significant improvement. Marked improvement occurred in 16 of 17 cases with symptoms for under 12 months, compared with 3 of 13 with longer duration. Homoeopathic aggravation occurred in 1 case (3.33%) and transient new symptoms in 5 cases (16.67%).
Conclusion: Improvement in pain and disability was observed over three months in patients with sciatica treated with individualized Rhus toxicodendron, most notably in those with shorter disease duration. Because there was no control group, effectiveness cannot be established, and randomized controlled trials are warranted.
Downloads
References
Valat JP, Genevay S, Marty M, Rozenberg S, Koes B. Sciatica. Best Pract Res Clin Rheumatol. 2010;24(2):241-52. doi:10.1016/j.berh.2009.11.005
Loscalzo J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s principles of internal medicine. 21st ed. New York: McGraw Hill; 2022.
Konstantinou K, Dunn KM. Sciatica: review of epidemiological studies and prevalence estimates. Spine. 2008;33(22):2464-72. doi:10.1097/BRS.0b013e318183a4a2
World Health Organization. International statistical classification of diseases and related health problems, 10th revision (ICD-10). Geneva: World Health Organization. [Add the edition/year and URL you actually used.]
Jacobs WCH, Van Tulder M, Arts M, Rubinstein SM, Van Middelkoop M, Ostelo R, et al. Surgery versus conservative management of sciatica due to a lumbar herniated disc: a systematic review. Eur Spine J. 2011;20(4):513-22. doi:10.1007/s00586-010-1603-7
Boericke W. Pocket manual of homoeopathic materia medica. New Delhi: B Jain Publishers; 2007.
Clarke JH. A dictionary of practical materia medica. New Delhi: B Jain Publishers; 1995.
Hering C. The guiding symptoms of our materia medica. Philadelphia: American Homoeopathic Publishing Society; J.M. Stoddart & Co; 1879. Available from: http://archive.org/details/guidingsymptomso00heri
Das SK, Basu T, Tabassum SN, Sarkar A, Ghosh S, Koley M, et al. Efficacy of individualized homeopathic medicines in the treatment of sciatica pain: double-blind, randomized, placebo-controlled trial. J Integr Complement Med. 2024;30(7):671-81. doi:10.1089/jicm.2023.0260
To AKL, Fok Y. Safety and efficacy of individualised homeopathic treatment in sciatica – a phase I pre-post comparison study [conference abstract]. 2020. doi:10.1055/s-0040-1702087
Yumnam M, Nerlekar MA. Evidence-based clinical study on pain management of sciatica with organ-specific homoeopathic medicines. Int J Drug Deliv Technol. 2026;16(11s). doi:10.25258/ijddt.16.11s.81
Pandey K. Sciatica pain – a homoeopathic approach. Afr J Biomed Res. 2024;27(6S):564-7. doi:10.53555/AJBR.v27i6S.7174
Sharma J, Chaudhary S. Chronic sciatica treated with individualized homoeopathic medicine: a case report. Int J Homoeopath Sci. 2024;8(1):3-7. doi:10.33545/26164485.2024.v8.i1a.1041
Sivakumar K, Krisna R, K. R. Intervertebral disc bulge with sciatica treated successfully with homoeopathy treatment: an evidence-based case report. Homoeopathic Links. 2026;39(1):42-7. doi:10.1055/s-0045-1809687
Jawara N, Lewith GT, Vickers AJ, Mullee MA, Smith C. Homoeopathic arnica and Rhus toxicodendron for delayed onset muscle soreness: a pilot for a randomized, double-blind, placebo-controlled trial. Br Homeopath J. 1997;86(1):10-5. doi:10.1016/S0007-0785(97)80004-X
Mathie RT. Specific effects of homeopathy: the challenge of explanatory research. Homeopathy. 2006;95:197-8. doi:10.1016/j.homp.2006.09.001
Fisher P, Greenwood A, Huskisson EC, Turner P, Belon P. Effect of homoeopathic treatment on fibrositis (primary fibromyalgia). BMJ. 1989;299(6695):365-6. doi:10.1136/bmj.299.6695.365
Schroyens F, editor. Synthesis repertory, version 9.1 [software]. RADAR Opus. [Add publisher, place and year.]
Hahnemann S. Organon of medicine. New Delhi: B Jain Publishers; 2005.
Kent JT. Lectures on Homoeopathic Philosophy. Philadelphia: Examiner Printing House; 1900. Lecture XXXV: Prognosis After Observing the Action of the Remedy.
Melzack R. The short-form McGill pain questionnaire. Pain. 1987;30(2):191-7. doi:10.1016/0304-3959(87)91074-8
Fairbank JCT, Pynsent PB. The Oswestry Disability Index. Spine. 2000;25(22):2940-53. doi:10.1097/00007632-200011150-00017
Ostelo RWJG, Deyo RA, Stratford P, Waddell G, Croft P, Von Korff M, et al. Interpreting change scores for pain and functional status in low back pain: towards international consensus regarding minimal important change. Spine. 2008;33(1):90-4. doi:10.1097/BRS.0b013e31815e3a10
Copay AG, Glassman SD, Subach BR, Berven S, Schuler TC, Carreon LY. Minimum clinically important difference in lumbar spine surgery patients: a choice of methods using the Oswestry Disability Index, Medical Outcomes Study questionnaire Short Form 36, and pain scales. Spine J. 2008;8(6):968-74. doi:10.1016/j.spinee.2007.11.006
Witt CM, Lüdtke R, Baur R, Willich SN. Homeopathic medical practice: long-term results of a cohort study with 3981 patients. BMC Public Health. 2005;5:115. doi:10.1186/1471-2458-5-115
Rihn JA, Hilibrand AS, Radcliff K, Kurd M, Lurie J, Blood E, et al. Duration of symptoms resulting from lumbar disc herniation: effect on treatment outcomes: analysis of the Spine Patient Outcomes Research Trial (SPORT). J Bone Joint Surg Am. 2011;93(20):1906-14. doi:10.2106/JBJS.J.00878
El Barzouhi A, Vleggeert-Lankamp CLAM, Lycklama à Nijeholt GJ, Van der Kallen BF, Van den Hout WB, Koes BW, et al. Influence of low back pain and prognostic value of MRI in sciatica patients in relation to back pain. PLoS One. 2014;9(3):e90800. doi:10.1371/journal.pone.0090800
Endrizzi C, Rossi E, Crudeli L, Garibaldi D. Harm in homeopathy: aggravations, adverse drug events or medication errors? Homeopathy. 2005;94(4):233-40. doi:10.1016/j.homp.2005.08.019
Dos Santos AL, Perazzo FF, Cardoso LGV, Carvalho JCT. In vivo study of the anti-inflammatory effect of Rhus toxicodendron. Homeopathy. 2007;96(2):95-101. doi:10.1016/j.homp.2007.03.001
Lee KJ, Yeo MG. Homeopathic Rhus toxicodendron has dual effects on the inflammatory response in the mouse preosteoblastic cell line MC3T3-e1. Homeopathy. 2016;105(1):42-7. doi:10.1016/j.homp.2015.09.004

